EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction of lignan glycosides biosynthetic network in Escherichia coli using mutltienzyme modules

Yuqi Qiao, Doudou Huang, Yajing Li, Songfan Jiang, Xiao Chen, Junfeng Chen, Ying Xiao, Wansheng Chen

Microbial Cell Factories · 2024

DOI: 10.1186/s12934-024-02467-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Cell Factories, 2024. Verfasst von Yuqi Qiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Center of Chinese Medicine Resources and Biotechnology, The Ministry of Education (MOE) Key Laboratory for Standardization o…. Hauptthemen laut MEDLINE: Lignans, Glycosides, Escherichia coli, Biosynthetic Pathways. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Program of Shanghai Academic/Technology Research Leader.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to the complexity of the metabolic pathway network of active ingredients, precise targeted synthesis of any active ingredient on a synthetic network is a huge challenge. Based on a complete analysis of the active ingredient pathway in a species, this goal can be achieved by elucidating the functional differences of each enzyme in the pathway and achieving this goal through different combinations. Lignans are a class of phytoestrogens that are present abundantly in plants and play a role in various physiological activities of plants due to their structural diversity. In addition, lignans offer various medicinal benefits to humans. Despite their value, the low concentration of lignans in plants limits their extraction and utilization. Recently, synthetic biology approaches have been explored for lignan production, but achieving the synthesis of most lignans, especially the more valuable lignan glycosides, across the entire synthetic network remains incomplete.

Results

By evaluating various gene construction methods and sequences, we determined that the pCDF-Duet-Prx02- Ps VAO gene construction was the most effective for the production of (+)-pinoresinol, yielding up to 698.9 mg/L after shake-flask fermentation. Based on the stable production of (+)-pinoresinol, we synthesized downstream metabolites in vivo. By comparing different fermentation methods, including “one-cell, one-pot” and “multicellular one-pot”, we determined that the “multicellular one-pot” method was more effective for producing (+)-lariciresinol, (-)-secoisolariciresinol, (-)-matairesinol, and their glycoside products. The “multicellular one-pot” fermentation yielded 434.08 mg/L of (+)-lariciresinol, 96.81 mg/L of (-)-secoisolariciresinol, and 45.14 mg/L of (-)-matairesinol. Subsequently, ultilizing the strict substrate recognition pecificities of UDP-glycosyltransferase (UGT) incorporating the native uridine diphosphate glucose (UDPG) Module for in vivo synthesis of glycoside products resulted in the following yields: (+)-pinoresinol glucoside: 1.71 mg/L, (+)-lariciresinol-4- O - d -glucopyranoside: 1.3 mg/L, (+)-lariciresinol-4’- O - d -glucopyranoside: 836 µg/L, (-)-secoisolariciresinol monoglucoside: 103.77 µg/L, (-)-matairesinol-4- O - d -glucopyranoside: 86.79 µg/L, and (-)-matairesinol-4’- O - d -glucopyranoside: 74.5 µg/L.

Conclusions

By using various construction and fermentation methods, we successfully synthesized 10 products of the lignan pathway in Isatis indigotica Fort in Escherichia coli , with eugenol as substrate. Additionally, we obtained a diverse range of lignan products by combining different modules, setting a foundation for future high-yield lignan production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansGlycosidesEscherichia coliBiosynthetic PathwaysMetabolic EngineeringFermentationSynthetic BiologyFurans

Stichwörter der Autor:innen

Escherichia coliHeterologous biosynthesisLignansModule assembly

Substanzen

LignansGlycosidespinoresinolFurans

Autor:innen und Institutionen

  • Research and Development Center of Chinese Medicine Resources and Biotechnology, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai Uni…
  • School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Shanghai Key Laboratory of Plant Molecular Sciences, College of Life Sciences, Shanghai Normal University, Shanghai, 200234, China.
  • Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China. chenwansheng@shutcm.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Program of Shanghai Academic/Technology Research Leader

Zitieren

APA

Qiao, Y., Huang, D., Li, Y., Jiang, S., Chen, X., Chen, J., Xiao, Y., & Chen, W. (2024). Construction of lignan glycosides biosynthetic network in Escherichia coli using mutltienzyme modules. Microbial Cell Factories. https://doi.org/10.1186/s12934-024-02467-1

Vancouver

Qiao Y, Huang D, Li Y, Jiang S, Chen X, Chen J, et al. Construction of lignan glycosides biosynthetic network in Escherichia coli using mutltienzyme modules. Microbial Cell Factories. 2024. doi:10.1186/s12934-024-02467-1

BibTeX
@article{Qiao2024,
  author = {Qiao, Yuqi and Huang, Doudou and Li, Yajing and Jiang, Songfan and Chen, Xiao and Chen, Junfeng and Xiao, Ying and Chen, Wansheng},
  title = {Construction of lignan glycosides biosynthetic network in Escherichia coli using mutltienzyme modules},
  journal = {Microbial Cell Factories},
  year = {2024},
  doi = {10.1186/s12934-024-02467-1}
}
Kostenlos starten →